Is SGHT's Q2 2025 EPS forecast too conservative?

**Sight Sciences' (SGHT) Q2 2025 EPS forecast appears to be cautiously optimistic rather than conservative** based on several points:

1. **Recent Financial Performance**: SGHT reported an EPS of -$0.23 for Q4 2024, which is in line with previous quarter performances, indicating a consistent financial trajectory. This suggests that the company's financial performance has not significantly improved to warrant a more aggressive EPS forecast for Q2 2025.

2. **Revenue Expectations**: Despite a slight miss in EPS, SGHT's revenue for Q4 2024 exceeded expectations, with a revenue of $19.07 million, beating the forecast by $0.07 million. This indicates a level of revenue consistency that does not necessarily support a more optimistic EPS forecast for the upcoming quarter.
3. **Executive Transactions**: Recent insider transactions show executives selling shares to cover tax liabilities, which could be interpreted as a lack of confidence in the company's short-term stock price appreciation. This sentiment could potentially lead to a more conservative EPS forecast as executives may be managing expectations.
4. **Analyst Ratings and Price Target Adjustments**: Stifel analysts recently adjusted their price target for SGHT from $5.00 to $4.00, maintaining a Buy rating. This adjustment reflects a more cautious outlook on the stock's future performance, which could influence a more conservative EPS forecast.
5. **Market Challenges**: SGHT has faced significant challenges, including a stock price hitting a 52-week low amid market challenges. These factors may lead to a more conservative EPS forecast as the company navigates through uncertain market conditions.

In conclusion, while SGHT has shown some positive revenue indicators, the company's consistent EPS performance, insider transactions, analyst ratings, and market challenges suggest that the Q2 2025 EPS forecast is more cautiously optimistic than conservative.